ENTITY
stringlengths 8
8
| DEFINITION
stringlengths 3
8.47k
⌀ | ALIASES
stringlengths 2
13.6k
⌀ | NAME
stringlengths 2
1.98k
|
|---|---|---|---|
C0323753 | null | loxosceles|Skin necrosis spider|Genus Loxosceles (organism)|Loxosceles|Loxosceles, NOS | Genus Loxosceles |
C0005658 | A wound inflicted by the teeth or fangs of an individual or animal. | bite|Bite Injury|Bite|bites|Bite wound|Bites|Bite (morphologic abnormality)|bite wound|biting|Bite, NOS | bite injury |
C0044369 | null | PLD|Pyridinium, 1-dodecyl-4-formyl-3-hydroxy-5-(hydroxymethyl)-2-methyl-, chloride | 1-dodecylpyridoxal |
C0005525 | Any substance that induces, enhances, restores or suppresses the host's immune system, or an agent that utilizes or is derived from a component of the immune system. | Immune Modulators|Immunotherapeutic Agent|Immunomodulating Agent|Immunotherapy|Immune Mediators|BRM|biological response modifier|Immunomodulatory Agent|Immunomodulators|Biological response modifiers|Biomodulators|Response Modifiers, Biological|biological response modifiers|Immune Regulators|Modifiers, Biological Response|Biological Response Modifier|Immunotherapy Agent|Biological Response Modifiers|Immunopotentiators | Biological Response Modifiers |
C0031640 | A class of enzymes that catalyze the hydrolysis of one of the two ester bonds in a phosphodiester compound. EC 3.1.4. | Phosphodiester hydrolase|Phosphoric Diester Hydrolases|PDE|phosphodiesterase|Substance with phosphodiesterase mechanism of action (substance)|Phosphoric diester hydrolase (substance)|Phosphodiesterase|phosphodiesterases|phosphoric diester hydrolase|Phosphoric diester hydrolase|Phosphodiesterases|Hydrolases, Phosphoric Diester | phosphoric diester hydrolase |
C0053625 | biotin in amide linkage with the epsilon amino group of lysine; occurs in the holoenzymes for which biotin is the coenzyme. | biotinyl-L-lysine|biocytin|biotinyl L lysine | biocytin |
C1285573 | The determination of the DNA sequence of an individual. | Genotype determination|Genotype determination (procedure)|Genotype Analysis|Genotyping|genotype|GENOTYPE|Genotype Assay|Genotyping (qualifier value)|Genotype | Genotype determination |
C0042210 | Suspensions of killed or attenuated microorganisms (bacteria, viruses, fungi, protozoa), antigenic proteins, synthetic constructs, or other bio-molecular derivatives, administered for the prevention, amelioration, or treatment of infectious and other diseases. | Therapeutic vaccine|Vaccine, NOS|Vaccine|Vaccine Therapy|vaccines|Vaccine product (product)|Vaccine product|Vaccine (substance)|Therapeutic vaccine, NOS|VaccineEntityType|vaccine product|therapeutic vaccine|therapeutic vaccines|VACCINES|vaccine|Vaccines | Vaccines |
C0041307 | An infection of cattle caused by MYCOBACTERIUM BOVIS. It is transmissible to man and other animals. | bovine tuberculosis|Tuberculoses, Bovine|Infection due to Mycobacterium bovis|cattle tuberculosis|Infection caused by Mycobacterium bovis|Bovine tuberculosis|Bovine Tuberculoses|Bovine Tuberculosis|Infection caused by Mycobacterium bovis (disorder)|Tuberculosis in cattle | Tuberculosis, Bovine |
C0014057 | A mosquito-borne encephalitis caused by the Japanese B encephalitis virus (ENCEPHALITIS VIRUS, JAPANESE) occurring throughout Eastern Asia and Australia. The majority of infections occur in children and are subclinical or have features limited to transient fever and gastrointestinal symptoms. Inflammation of the brain, spinal cord, and meninges may occur and lead to transient or permanent neurologic deficits (including a POLIOMYELITIS-like presentation); SEIZURES; COMA; and death. (From Adams et al., Principles of Neurology, 6th ed, p751; Lancet 1998 Apr 11;351(9109):1094-7) | Japanese encephalitis virus disease|Japanese B Encephalitis|JE - Japanese encephalitis|Japanese encephalitis|ENCEPHALITIS, RUSSIAN AUTUMNAL|Japanese b encephalitis|encephalitis Japanese|JBE - Japanese B encephalitis|Viral Encephalitis, Japanese B|ENCEPHALITIS, SUMMER|Japanese encephalitis virus disease (disorder)|Japanese B Viral Encephalitis|ENCEPHALITIS, JAPANESE B|Encephalitis, Japanese|Encephalitis, Japanese B|Japanese B encephalitis|Japanese Encephalitis | Japanese Encephalitis |
C0014061 | Encephalitis caused by neurotropic viruses that are transmitted via the bite of TICKS. In Europe, the diseases are caused by ENCEPHALITIS VIRUSES, TICK-BORNE, which give rise to Russian spring-summer encephalitis, central European encephalitis, louping ill encephalitis, and related disorders. Powassan encephalitis occurs in North America and Russia and is caused by the Powassan virus. ASEPTIC MENINGITIS and rarely encephalitis may complicate COLORADO TICK FEVER which is endemic to mountainous regions of the western United States. (From Joynt, Clinical Neurology, 1996, Ch26, pp14-5) | Encephalitis, Tick-borne|tick borne encephalitis|Tick-borne viral encephalitis, unspecified|Viral encephalitis transmitted by tick (navigational concept)|Tick-Borne Encephalitis|Encephalitis, Tick-Borne|tick-borne encephalitis|Viral encephalitis transmitted by tick|Encephalitis due to tick-borne encephalitis virus (navigational concept)|Tick-borne viral encephalitis|Tick Borne Encephalitis|Encephalitis, Tick Borne|Tick-Borne Viral Encephalitis|Tick-borne encephalitis|Tick-borne viral encephalitis, NOS | Tick-Borne Encephalitis |
C0034861 | Proteins prepared by recombinant DNA technology. | Recombinant protein (substance)|protein recombinant|recombinant protein|Recombinant proteins|Proteins, Biosynthetic|recombinant proteins|protein recombinants|Proteins, Recombinant|Recombinant protein|Recombinant Protein|Biosynthetic Proteins | Recombinant Proteins |
C0052416 | An inorganic compound with the chemical formula As2O3 that is used for the treatment of ACUTE PROMYELOCYTIC LEUKEMIA in patients who have relapsed from, or are resistant to, conventional drug therapy. | As2O3|Arsenic(III) oxide|Arsenic trioxide|Diarsenic oxide|Arsenigen Saure|arsenic trioxide|Arsenic Trioxide|Arsenic (III) Oxide|Arsenous oxide|arsénico trióxido|Arsenic Sesquioxide|White Arsenic|Arsenic oxide|Arsenic(III) Oxide|Arsenous Oxide|Acide Arsenieux|Arsenic trioxide-containing product|White arsenic|Arsenic trioxide (substance)|ATO|ARSENIC TRIOXIDE|Arsenolite|Arsenic Blanc|Diarsenic Trioxide|AS2O3|Arsenic Oxide (As2O3)|Product containing arsenic trioxide (medicinal product)|Diarsenic trioxide | arsenic trioxide |
C0999517 | null | Saimiri sciureus|Common squirrel monkey|South American squirrel monkey|Saimiri sciureus (organism) | Saimiri sciureus |
C0052416 | An inorganic compound with the chemical formula As2O3 that is used for the treatment of ACUTE PROMYELOCYTIC LEUKEMIA in patients who have relapsed from, or are resistant to, conventional drug therapy. | As2O3|Arsenic(III) oxide|Arsenic trioxide|Diarsenic oxide|Arsenigen Saure|arsenic trioxide|Arsenic Trioxide|Arsenic (III) Oxide|Arsenous oxide|arsénico trióxido|Arsenic Sesquioxide|White Arsenic|Arsenic oxide|Arsenic(III) Oxide|Arsenous Oxide|Acide Arsenieux|Arsenic trioxide-containing product|White arsenic|Arsenic trioxide (substance)|ATO|ARSENIC TRIOXIDE|Arsenolite|Arsenic Blanc|Diarsenic Trioxide|AS2O3|Arsenic Oxide (As2O3)|Product containing arsenic trioxide (medicinal product)|Diarsenic trioxide | arsenic trioxide |
C0950022 | null | Hinoki Cypress|Chamaecyparis obtusa|obtusas, Chamaecyparis|Cypress, Hinoki|Chamaecyparis obtusas | Chamaecyparis obtusa |
C1121924 | null | null | yatein |
C1148435 | null | Ribonucleic acid of West Nile virus (substance)|Ribonucleic acid of West Nile virus | West Nile virus RNA |
C0006356 | A species of the true toads, Bufonidae, widely distributed in the United States and Europe. | European common toad (organism)|Toad, Common|Common Toad|common European toad|Common Toads|Rana bufo|European common toad|Bufo bufo|European toad|Toads, Common | Bufo bufo |
C0006354 | null | bufo toad|Bufos|Torrentophryne|Genus Bufo (organism)|Bufo|Genus Bufo|bufo | bufo toad |
C0596121 | Organisms that live in water. | aquatic organism|Aquatic Organism|Aquatic organisms|Organism, Aquatic|Organisms, Aquatic | Aquatic Organisms |
C0998824 | null | Acipenser guldenstadti|Caspian sturgeon|osietra|Acipenser gueldenstaedti | Acipenser gueldenstaedtii |
C0005540 | Research that involves the application of the natural sciences, especially biology and physiology, to medicine. | Research, Biomedical|biomedical research|Biomedical Research | Biomedical Research |
C0005540 | Research that involves the application of the natural sciences, especially biology and physiology, to medicine. | Research, Biomedical|biomedical research|Biomedical Research | Biomedical Research |
C0010678 | Infection with CYSTICERCUS, the larval form of the various tapeworms of the genus Taenia (usually T. solium in man). In humans they penetrate the intestinal wall and invade subcutaneous tissue, brain, eye, muscle, heart, liver, lung, and peritoneum. Brain involvement results in NEUROCYSTICERCOSIS. | Infection caused by tapeworm larvae|cysticercoses|Cysticercosis (disorder)|cysticercosis|Cysticercosis|Cysticerciasis|Infection by tapeworm larvae|Larval teniasis|Larval taeniasis|CYSTICERCOSIS|INFECTIONS BY TAPEWORM LARVAE|Infection caused by tapeworm larvae (disorder)|Larval tapeworm infection|Cysticercoses | Cysticercosis |
C1254573 | null | Mature erythrocyte | Mature Erythrocytes |
C0034709 | A strain of Rattus norvegicus used as a normotensive control for the spontaneous hypertensive rats (SHR). | WKY, Rat Strain|Rats, Wistar Kyoto|Wistar Kyoto Rats|Inbred WKY Rats|WKY Rat, Inbred|WKY|Rat, WKY|WISTAR KYOTO|WKY Rat|Kyoto Wistar rat (organism)|Rat, Inbred WKY|Rats, WKY|WKY Rats|WKY Rats, Inbred|Inbred WKY Rat|Wistar Kyoto|Kyoto Wistar rat | Rats, Inbred WKY |
C0018296 | Enzymes that hydrolyze GTP to GDP. EC 3.6.1.-. | GTP Phosphohydrolases|GTPase|Guanosinetriphosphatases|GTPases|gtpase|gtpases|Phosphohydrolase, GTP|guanosinetriphosphatase|Phosphohydrolases, Guanosine Triphosphate|Guanosine Triphosphate Phosphohydrolases|Triphosphate Phosphohydrolases, Guanosine|Guanosinetriphosphatase|GTP Phosphohydrolase|Phosphohydrolases, GTP|GTP phosphohydrolase | Guanosine Triphosphate Phosphohydrolases |
C0005911 | A clinical manifestation consisting of alterations in an individual's weight from his or her norm. | Weight Change|Body Weight Change|change weight|weight change|Weight change (observable entity)|Change, Body Weight|body change weight|Weight Change, Body|body weight change|weight changes|Weight change|Changes, Body Weight|Weight Changes, Body | Body Weight Changes |
C0015806 | Fractures of the short, constricted portion of the thigh bone between the femur head and the trochanters. It excludes intertrochanteric fractures which are HIP FRACTURES. | fracture of neck of femur|Fracture of neck of femur|NOF - Fracture of neck of femur|Femur Neck Fracture|Femur Neck Fractures|fracture neck of femur|fractured neck of femur|femoral fracture neck|femur neck fracture|fractured neck femur|femoral neck fractures|femur fracture neck|fracture femoral neck|Fracture of neck of femur (disorder)|Femoral Neck Fracture|neck of femur fracture|femur fractures neck|femoral neck fracture|femoral fractures neck|femur fractured neck|Femoral neck fracture|fracture neck femur|fracture of neck femur | Femoral Neck Fractures |
C0038842 | null | Supervision (regime/therapy)|Supervision|supervision | Supervision (regime/therapy) |
C0150223 | null | prevention fall|falling preventions|falls prevention|Fall prevention|fall prevention|fall preventions|Fall prevention (procedure) | Fall prevention |
C0011438 | The profession concerned with the teeth, oral cavity, and associated structures, and the diagnosis and treatment of their diseases including prevention and the restoration of defective and missing tissue. | Dentistry (qualifier value)|dentistry (field)|Dentistry|dentistry | Dentistry |
C0029355 | A specialty which utilizes medical, surgical, and physical methods to treat and correct deformities, diseases, and injuries to the skeletal system, its articulations, and associated structures. | orthopaedic|Orthopedic|orthopedics surgery|orthopedics|Orthopedic Surgical Profession|orthopedics (profession)|Orthopedic Surgery|orthopedic surgery|orthopaedics|Orthopedics|surgery orthopedic|orthopedic | Orthopedics |
C0678908 | null | brain functions|brain function | brain function |
C0015663 | Abstaining from FOOD. | fasting|fasting states|fasted state|Fast|Fasting (finding)|Fasting|fast state|FASTING|Fasting state | Fasting |
C0007806 | A watery fluid that is continuously produced in the CHOROID PLEXUS and circulates around the surface of the BRAIN; SPINAL CORD; and in the CEREBRAL VENTRICLES. | FLUID, CEREBROSPINAL|Cerebrospinal fluid, NOS|Cerebral Spinal Fluid|cerebrospinal fluid|CSF|Fluids, Cerebro Spinal|Spinal Fluid, Cerebro|Cerebrospinal fluid|Spinal Fluid|Cerebrospinal Fluids|Fluid, Cerebrospinal|Spinal Fluids, Cerebro|spinal fluid|cerebrospinal fluid (CSF)|Cerebrospinal Fluid|Spinal fluid|Liquor cerebrospinalis|Fluids, Cerebrospinal|Portion of cerebrospinal fluid|CEREBROSPINAL FLUID|Fluid, Cerebro Spinal|Cerebro Spinal Fluids|Cerebro Spinal Fluid|CSF - Cerebrospinal fluid|Cerebrospinal fluid (substance) | Cerebrospinal Fluid |
C1527077 | A minimally invasive form of electroanalgesia involving stimulation of the dermatomal bands proximal to the affected area. It is often used in the treatment of intractable chronic lower back pain, cancer pain, and other painful disorders. (from White, Li, and Chiu) | PENS | Peripheral Electronic Nerve Stimulation |
C0067724 | null | N acetyl L glutamate | N-acetylglutamate |
C0233514 | Troublesome or disruptive behavioral displays. | Abnormal Behavior|abnormal behavior|Not Acting Self|Behavioral abnormality|Behavioral problems|Behavioral/psychiatric abnormalities|Behavioral problem|Behavioral Problems|Behavioral abnormalities|Problem Behaviors|Problem behavior|behavior problem|Disturbance of conation|Psychiatric disorders|Behavioural problem|problems behavior|Behavioural concern|Behavioral disorders|Abnormal conduct|Not Acting Normal|behaviors problem|Abnormal behavior (finding)|strange behavior|behaviour problems|BEHAVIOR ABNORMAL|Strange behavior|strange behaviour|Abnormal behavior|behaviours problem|Problem behavior (finding)|Behavioral disturbances|Behavioral Disturbance|BEHAVIORAL PROBLEM|Problem behaviour|Psychiatric disturbances|behavior problems|behaviour problem|Problem, Behavioral|Problems, Behavioral|Disturbance of conation, NOS|Behavioral concern|Behavior problems|Abnormal conduct, NOS|Strange behaviour|Behavioural/Psychiatric abnormality|problem behaviour|behavioural problems|Behavioral Problem|Behavioral changes|behavioral problems|Behaviors, Problem|Problem Behavior|Abnormal behavior, NOS|abnormal behaviour|behavioral problem|Behavior, Problem|BEHAVIOR PROBLEMS|problem behavior|Abnormal behaviour | Abnormal behavior |
C0009443 | A catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. It generally involves a runny nose, nasal congestion, and sneezing. | acute rhinitis|Head cold, NOS|Common cold|Nasopharyngitis, acute|acute coryza|COMMON COLD|Common Cold|Common Colds|Acute rhinitis|Rhinitis infective|Infectious Rhinitis|colds|Non-Allergic Rhinitis|Infective rhinitis|common colds|Coryza|Colds, Common|Cold (Disease)|Rhinitis, infective|Acute nasopharyngitis|Infective nasopharyngitis|Nasal catarrh, acute|CORYZA|Acute Nasopharyngitis|common cold|Rhinitis, acute|Acute nasal catarrh|Acute coryza|Cold, common|Cold, Common|Cold|RHINITIS, ACUTE|Infective nasopharyngitis, NOS|acute nasopharyngitis|VIRAL UPPER RESPIRATORY INFECTION|cold|head cold|Coryza, acute|Infective nasopharyngitis NOS|Acute rhinitis (disorder)|Acute nasopharyngitis, NOS|Acute infective rhinitis|Head cold|Common cold (disorder)|Acute nasopharyngitis [common cold] | Common Cold |
C0016514 | A highly infectious disease caused by FOOT AND MOUTH DISEASE VIRUS that affects mammals of the ARTIODACTYLA order (CATTLE; SHEEP; GOATS; and PIGS) and is characterized by high fever followed by the appearance of blisters inside the mouth and on the feet. | foot mouth disease|aphthosis|Foot-and-Mouth Diseases|Epizootic aphtae|Hoof-and-mouth disease|FEVER, APHTHOUS|Foot-and-mouth disease|Aphthous fever|Foot-and-mouth disease (disorder)|Foot and mouth disease|Aphthus fever|Diseases, Foot-and-Mouth|hoof-and-mouth disease|FOOT AND MOUTH DISEASE|mouth foot disease|disease foot-and-mouth|Disease, Foot-and-Mouth|EPIZOOTIC APHTHAE|Foot and Mouth Disease|disease foot mouth|disease foot and mouth|Foot-and-Mouth Disease|aphthous fever|Epizootic aphthae|Epizootic stomatitis|mouth disease foot|foot and mouth disease|foot-and-mouth disease | Foot-and-Mouth Disease |
C0031886 | A family of small RNA viruses comprising some important pathogens of humans and animals. Transmission usually occurs mechanically. There are nine genera: APHTHOVIRUS; CARDIOVIRUS; ENTEROVIRUS; ERBOVIRUS; HEPATOVIRUS; KOBUVIRUS; PARECHOVIRUS; RHINOVIRUS; and TESCHOVIRUS. | Picornavirus group, NOS|picornavirus|Family Picornaviridae (organism)|Picornaviridae|Picornaviruses|Picornavirus group|PICORNAVIRUS|Family Picornaviridae|picornaviruses|picornaviridae|Picornavirus | Family Picornaviridae |
C0032371 | An acute infectious disease of humans, particularly children, caused by any of three serotypes of human poliovirus (POLIOVIRUS). Usually the infection is limited to the gastrointestinal tract and nasopharynx, and is often asymptomatic. The central nervous system, primarily the spinal cord, may be affected, leading to rapidly progressive paralysis, coarse FASCICULATION and hyporeflexia. Motor neurons are primarily affected. Encephalitis may also occur. The virus replicates in the nervous system, and may cause significant neuronal loss, most notably in the spinal cord. A rare related condition, nonpoliovirus poliomyelitis, may result from infections with nonpoliovirus enteroviruses. (From Adams et al., Principles of Neurology, 6th ed, pp764-5) | Poliomyelitis Infection|acute polio|Epidemic acute poliomyelitis, NOS|Acute poliomyelitis, unspecified|acute poliomyelitis|Acute Poliomyelitis, Epidemic|Poliomyelitis, Epidemic Acute|poliomyelitis|Polia|Acute poliomyelitis, NOS|Infections, Poliomyelitis|polio|Acute poliomyelitis (disorder)|Polio|PM - Poliomyelitis|Acute Poliomyelitis|polios|HEINE-MEDIN DISEASE|Infection, Poliomyelitis|Poliomyelitis Infections|Acute poliomyelitis|Epidemic Acute Poliomyelitis|Epidemic acute poliomyelitis (disorder)|POLIOMYELITIS|Poliomyelitis, Acute|Poliomyelitis|Epidemic acute poliomyelitis|Polios|Poliomyelitis, NOS | Poliomyelitis |
C0021270 | A child between 1 and 23 months of age. | Infants|Infant (person)|infant|Baby|INFANT|babies|BABY|infants|baby|Infant | Infant |
C0238598 | A person between 19 and 24 years of age. | Young Adults|Young adults|Young Adult|Adults, Young|young adult|Adult Youth|Adult, Young|ADULT, YOUNG | Young Adult |
C0021270 | A child between 1 and 23 months of age. | Infants|Infant (person)|infant|Baby|INFANT|babies|BABY|infants|baby|Infant | Infant |
C0205653 | A person 13 to 18 years of age. | Adolescents|Adolescent (person)|Adolescent|teenager|pubescent|teenagers|adolescents|teens|adolescent|teen|Adolescent Youth|ADOLESCENT | Adolescent (age group) |
C0949771 | Cellular proteins and protein complexes that transport amino acids across biological membranes. | Amino Acid Channel|Amino Acid Transport Protein|Amino Acid Transporter|Transporters, Amino Acid|Amino Acid Transport Systems|Amino Acid Transporters | Amino Acid Transporter |
C1024116 | null | Aquifex aeolicus | Aquifex aeolicus |
C1005349 | null | Finless porpoise|Neophocaena phocaenoides|Neophocaena phocanoides | Neophocaena phocaenoides |
C0032713 | Mammals of the family Phocoenidae comprising four genera found in the North Pacific Ocean and both sides of the North Atlantic Ocean and in various other seas. They differ from DOLPHINS in that porpoises have a blunt snout and a rather stocky body while dolphins have a beak-like snout and a slender, streamlined body. They usually travel in small groups. (From Walker's Mammals of the World, 5th ed, pp1003-4) | Porpoise|porpoise|Family Phocoenidae|Porpoise (organism)|Porpoises|Family Phocoenidae (organism)|Porpoise, NOS|porpoises|Phocoenidae | Porpoises |
C0225324 | null | Blubber (body structure)|Blubber, NOS|blubber|Blubber | Blubber |
C0920545 | null | health organization|health organizations | health organization |
C0599621 | null | object recognition | object recognition |
C0018870 | The back (or posterior) of the foot in PRIMATES, found behind the ankle and distal to the toes. | heels|Region of heel|Heel region|Heel structure|Heel|Heel structure (body structure)|Regio calcanea|Calx|heel|Calcaneal region|Heels | Heel |
C0019908 | null | Hoofs|Hoof, NOS|Hoof structure|hoofed|Hooves|hoof|Hoof structure (body structure)|Hoof|hooves | Hoof |
C0019939 | Either of the pair of hard processes, including ANTLERS, that consist of a BONE core surrounded by a middle KERATIN layer which is in turn covered by EPIDERMIS. They grow from the upper portion of the head of many RUMINANTS. | Horn structure|Horns|horns|horn|Horn, NOS|Horn|Horn structure (body structure) | Horns |
C0522772 | A scraping away of thin sections | shaving|Shaving|shave|Shaving - action|Shaving (procedure)|Shaving - action (qualifier value) | Shaving - surgical procedure |
C0016564 | A highly reactive aldehyde gas formed by oxidation or incomplete combustion of hydrocarbons. In solution, it has a wide range of uses: in the manufacture of resins and textiles, as a disinfectant, and as a laboratory fixative or preservative. Formaldehyde solution (formalin) is considered a hazardous compound, and its vapor toxic. (From Reynolds, Martindale The Extra Pharmacopoeia, 30th ed, p717) | formaldehyde|Oxomethane|Oxomethylene|Oxymethylene|Product containing formaldehyde (medicinal product)|Formaldehído|Methyl aldehyde|Methanal|Formic Aldehyde|Formaldehyde-containing product|FORMALDEHYDE (FORMALIN, FORMOL)|Methyl Aldehyde|methanal|Formaldehyde|FORMALDEHYDE|Formaldehyd|Methylene oxide|Formaldehyde (substance)|Formic aldehyde | formaldehyde |
C0017814 | One of the protein CROSS-LINKING REAGENTS that is used as a disinfectant for sterilization of heat-sensitive equipment and as a laboratory reagent, especially as a fixative. | Pentanedial|Product containing glutaraldehyde (medicinal product)|Glutaral|Glutardialdehyde|Glutaraldehyde-containing product|Glutaraldehyde|GLUTARAL|glutaraldehyde|GLUTARALDEHYDE|glutaral|Glutaraldehyde (substance) | glutaral |
C0054308 | null | butanal|butyraldehyde|Butyraldehyde|Butyraldehyde (substance)|1-butanal|Butanal | butyraldehyde |
C0016564 | A highly reactive aldehyde gas formed by oxidation or incomplete combustion of hydrocarbons. In solution, it has a wide range of uses: in the manufacture of resins and textiles, as a disinfectant, and as a laboratory fixative or preservative. Formaldehyde solution (formalin) is considered a hazardous compound, and its vapor toxic. (From Reynolds, Martindale The Extra Pharmacopoeia, 30th ed, p717) | formaldehyde|Oxomethane|Oxomethylene|Oxymethylene|Product containing formaldehyde (medicinal product)|Formaldehído|Methyl aldehyde|Methanal|Formic Aldehyde|Formaldehyde-containing product|FORMALDEHYDE (FORMALIN, FORMOL)|Methyl Aldehyde|methanal|Formaldehyde|FORMALDEHYDE|Formaldehyd|Methylene oxide|Formaldehyde (substance)|Formic aldehyde | formaldehyde |
C0012920 | DNA TOPOISOMERASES that catalyze ATP-independent breakage of one of the two strands of DNA, passage of the unbroken strand through the break, and rejoining of the broken strand. DNA Topoisomerases, Type I enzymes reduce the topological stress in the DNA structure by relaxing the superhelical turns and knotted rings in the DNA helix. | Untwisting enzyme|DNA Topoisomerase|DNA Relaxing Enzyme|Nicking-closing enzyme|untwisting enzyme|Deoxyribonucleic acid topoisomerase|DNA Nicking-Closing Protein|nicking closing enzyme|relaxing enzyme|DNA Relaxing Enzymes|DNA Nicking-Closing Proteins|DNA Topoisomerase I|Deoxyribonucleic acid topoisomerase (substance)|Type I DNA Topoisomerase|DNA Relaxing Protein|DNA Untwisting Enzymes|Topoisomerase I|DNA Untwisting Protein|DNA topoisomerase|DNA Topoisomerases, Type I|Relaxing enzyme|swivelase|Swivelase|DNA topoisomerase I|dna i topoisomerase|topoisomerase i|w-Protein|DNA Untwisting Proteins|topoisomerase I|DNA Type 1 Topoisomerase|type I DNA topoisomerase|DNA Untwisting Enzyme|Type I DNA topoisomerase | DNA Topoisomerases, Type I |
C0014432 | Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. | Product containing enzyme inhibitor (product)|Enzyme inhibitor|Substance with enzyme inhibitor mechanism of action (substance)|Enzyme inhibitor-containing product|Enzyme inhibitors|Inhibitors, Enzyme|enzymes inhibitors|enzyme inhibitors|Enzyme Inhibitors|enzyme inhibitor | Enzyme Inhibitors |
C0600531 | A human cell line established from a diffuse histiocytic lymphoma (HISTIOCYTIC LYMPHOMA, DIFFUSE) and displaying many monocytic characteristics. It serves as an in vitro model for MONOCYTE and MACROPHAGE differentiation. | U937 Cell|Cells, U937|u937 cells|u937 cell|cells u937|Cell, U937 | U937 Cells |
C0106158 | Transforming growth factor beta receptor type 3 (851 aa, ~93 kDa) is encoded by the human TGFBR3 gene. This protein is involved in TGF-beta binding. | Beta-Glycan|Betaglycan|TGFR3|betaglycan|TGF-Beta Receptor Type 3|beta glycan|Transforming Growth Factor Beta Receptor Type III|TGF-beta type III receptors|TGF beta type III receptor|TGFR-3|Transforming Growth Factor Beta Receptor III|transforming growth factor beta type III receptor|TRANSFORMING GROWTH FACTOR BETA RECEPTOR TYPE 3|TGFBR3|Transforming Growth Factor Beta Receptor Type 3|beta-glycan|TGF-Beta Receptor Type III|receptor, TGF-beta type III|type III TGFbeta receptor | TGF beta type III receptor |
C0870935 | A short sleep, usually during normal waking hours. | napping|nap|Nap | Napping |
C0235974 | A carcinoma arising from the exocrine pancreas. The overwhelming majority of pancreatic carcinomas are adenocarcinomas. | Carcinoma of Pancreas|Cancer of the Pancreas|Carcinoma of pancreas (disorder)|Pancreatic Carcinoma|pancreatic carcinoma|Pancreatic Acinar Carcinoma|Pancreas Cancer|Pancreatic cancer (excluding Islets), NOS|PANCREATIC CANCER|CARCINOMA OF PANCREAS|Pancreatic Cancer|pancreas carcinoma|pancreatic cancer|Pancreas Carcinoma|PANCREATIC CARCINOMA|PANCREATIC ACINAR CARCINOMA|Pancreatic cancer (not Islets)|Pancreatic carcinoma|carcinoma of pancreas|carcinoma pancreas|exocrine cancer|Exocrine Pancreas Carcinoma|carcinoma pancreatic|Cancer of Pancreas|Carcinoma of pancreas|Carcinoma of the Pancreas | Pancreatic carcinoma |
C0346647 | A primary or metastatic malignant tumor involving the pancreas. Representative examples include carcinoma and lymphoma. -- 2003 | pancreas cancer|Cancer of the Pancreas|Cancer of the pancreas|pancreatic cancers|Pancreas Cancer|Malignant tumour of pancreas|Pancreas--Cancer|Cancer of pancreas|Cancers, Pancreas|Pancreas Cancers|Malignant tumor of pancreas|Malignant neoplasm of pancreas, part unspecified|CA - Cancer of pancreas|malignant neoplasm of pancreas|Malignant neoplasm of pancreas, NOS|Pancreatic Cancer|Pancreatic Cancers|CA - Pancreatic cancer|Malignant tumor of pancreas (disorder)|Malignant Pancreatic Neoplasm|Malignant neoplasm of pancreas|pancreatic cancer|Malignant Neoplasm of Pancreas|Pancreatic cancer|Cancer, Pancreatic|Malignant Neoplasm of the Pancreas|cancer of the pancreas|Cancers, Pancreatic|pancreas ca|Cancer, Pancreas|Cancer of Pancreas|PANCREAS NEOPLASM MALIGNANT | Malignant neoplasm of pancreas |
C0963679 | null | FR 901228|FR-901228|Antibiotic FR 901228|FR901228 | FR 901228 |
C0215862 | A compound that selectively inhibits protein tyrosine kinase and nerve growth factor-dependent tyrosine phosphorylation. (NCI) | AG 879|AG879|Tyrphostin AG 879 | AG-879 |
C1171350 | null | Kinase Inhibitor|Kinase Inhibitor [EPC] | kinase inhibitor [EPC] |
C0963679 | null | FR 901228|FR-901228|Antibiotic FR 901228|FR901228 | FR 901228 |
C1334792 | An invasive prostate adenocarcinoma characterized by the presence of malignant cells exhibiting moderate differentiation. | null | Moderately Differentiated Prostate Adenocarcinoma |
C1334792 | An invasive prostate adenocarcinoma characterized by the presence of malignant cells exhibiting moderate differentiation. | null | Moderately Differentiated Prostate Adenocarcinoma |
C0314596 | null | cfu s|Colony-forming unit, spleen|CFU-S|Spleen colony-forming unit (cell)|cfu-s | Spleen colony-forming unit |
C0392143 | null | Organochlorine pesticide (substance) | Organochlorine pesticide |
C0002011 | A highly poisonous substance that was formerly used as an insecticide. The manufacture and use has been discontinued in the U.S. (From Merck Index, 11th ed) | Aldrin (substance)|aldrin|1,4:5,8-Dimethanonaphthalene, 1,2,3,4,10,10-hexachloro-1,4,4a,5,8,8a-hexahydro-, (1alpha,4alpha,4abeta,5alpha,8alpha,8abeta)-|Aldrin | Aldrin |
C0019219 | A man-made compound previously used to control termites and other insects. Even though production of heptachlor was phased out of use in the United States during the late 1980's it remains in soil and hazardous waste sites. It is clearly toxic to animals and humans but, the International Agency for Research on Cancer (IARC) has determined that heptachlor is not classifiable as to its carcinogenicity to humans. (From ATSDR Public Heath Statement, April 1989) | 4,7-Methano-1H-indene, 1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro-|Heptachlor|Heptachlor (substance) | Heptachlor |
C0078476 | null | ASC carbon | Whetlerite |
C0071499 | white, water soluable polymer based on acrylamide; used as a thickening or suspending agent in water based formulations. | poly(AAm)|Polyacrylamide|polyacrylamides|polyacrylamide|Polyacrylamide (substance) | polyacrylamide |
C1269079 | null | Entire hind limb|Entire LL - Lower limb|Entire leg|Entire lower limb|Entire lower limb (body structure) | Entire lower limb |
C0006647 | null | CAFFEINE INTOXICATION|Caffeine intoxication | Caffeine Intoxication |
C0002736 | A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94) | Bulbar motor neuron disease|Amyotrophic Lateral Sclerosis/Progressive Muscular Atrophy|amyotrophic laterals sclerosis|Sclerosis, Amyotrophic Lateral|Motor Neuron Disease, Amyotrophic Lateral Sclerosis|Motor neuron disease, bulbar|ALS Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis|Gehrig Disease|Gehrig's Disease|lou gehrigs disease|Amyotrophic lateral sclerosis|Lou Gehrig's disease (ALS)|AMYOTROPHIC LATERAL SCLEROSIS|Amyotrophic lateral sclerosis (disorder)|Lou Gehrig's Disease|lou gehrig disease|LOU GEHRIG DISEASE|ALS - Amyotrophic lateral sclerosis|Lou Gehrig's disease|Gehrigs Disease|ALS - Amyotrophic Lateral Sclerosis|Amyotrophic Lateral Sclerosis|Amytrophic lateral sclerosis|Charcot Disease|lou gehrig's disease|ALS|Lou Gehrig Disease|Disease, Lou-Gehrigs|Lou-Gehrigs Disease | Amyotrophic Lateral Sclerosis |
C0021770 | Cytoplasmic filaments intermediate in diameter (about 10 nanometers) between the microfilaments and the microtubules. They may be composed of any of a number of different proteins and form a ring around the cell nucleus. | Intermediate Filament|Intermediate filament|intermediate filaments|Filaments, Intermediate|intermediate filament|Intermediate filaments|Filament, Intermediate | Intermediate Filaments |
C0018165 | A group of peptide antibiotics from BACILLUS brevis. Gramicidin C or S is a cyclic, ten-amino acid polypeptide and gramicidins A, B, D are linear. Gramicidin is one of the two principal components of TYROTHRICIN. | GRAMICIDIN|Product containing gramicidin (medicinal product)|Gramicidin-containing product|gramicidin|Gramicidina|Gramicidins|Gramicidin (substance)|Gramicidin|Gramicidine | gramicidin |
C0043162 | Irradiation of the whole body with ionizing or non-ionizing radiation. It is applicable to humans or animals but not to microorganisms. | Whole-Body Radiation|Irradiation, Total Body|body irradiation total|Whole Body Irradiation|TOTAL BODY IRRADIATION|whole body irradiation|Whole-Body Radiations|Total body irradiation (procedure)|whole-body irradiation|Radiation, Whole-Body|Irradiation, Whole Body|Irradiation, Whole-Body|Whole-Body Irradiations|Total body irradiation|Total-Body Irradiation|Irradiations, Total Body|Total Body Irradiations|Irradiations, Whole-Body|total body irradiation|Total Body Irradiation|Radiations, Whole-Body|TBI|total-body irradiation|Radiation, Whole Body|Whole Body Radiation|Whole-Body Irradiation | Whole-Body Irradiation |
C0000097 | A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease. | mptp|Pyridine, 1,2,3,6-tetrahydro-1-methyl-4-phenyl-|Methylphenyltetrahydropyridine|methylphenyltetrahydropyridine|1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)|N-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine|MPTP|Methylphenyltetrahydropyridine (substance) | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
C0232487 | null | Abdominal discomfort (finding)|abdomen discomfort|Abdominal discomfort|ABDOMINAL DISCOMFORT|abdominal discomfort|DISCOMFORT ABDOMINAL | Abdominal discomfort |
C0814120 | null | early disease onset|disease early onset|early onset disorder | early disease onset |
C0006868 | null | Abuse, Cannabis|Cannabis abuse|abuse cannabis|Cannabis Abuse|cannabis abuse|Cannabis abuse (disorder) | Cannabis Abuse |
C0016163 | A group of cold-blooded, aquatic vertebrates having gills, fins, a cartilaginous or bony endoskeleton, and elongated bodies covered with scales. | Pisces|Fish (NOS)|Fish (organism)|fish|Fish|Finfish|FISH|Fishes|pisces|Fish, NOS|FISHES | Fishes |
C0233523 | Describes behavior that ignores the rights of others and the practices and laws of society. | SOCIOPATHY|anti-social behaviour|Antisocial behavior|Antisocial behavior (finding)|REACTION ASOCIAL|anti-social behavior|antisocial behavior|antisocial|antisocial behaviors|sociopathology|anti social behavior|Antisocial behaviour|sociopathy|Antisocial Behavior|REACTION ANTISOCIAL|ASOCIAL REACTION|ANTISOCIAL REACTION|antisocial behaviour | Antisocial behavior |
C0338451 | The most common clinical form of FRONTOTEMPORAL LOBAR DEGENERATION, this dementia presents with personality and behavioral changes often associated with disinhibition, apathy, and lack of insight. | Frontotemporal Dementia, Ubiquitin-Positive|Frontotemporal Dementia with Parkinsonism 17|Ubiquitin-Positive Frontotemporal Dementias|FLDEM|Pick's Disease, Familial|Dementias, Frontotemporal|FTDP17|Dementias, Frontotemporal Lobe (FLDEM)|Disinhibition-Dementia-Parkinsonism-Amytrophy Complices|Dementia, Frontotemporal, with Parkinsonism|Disease, Familial Pick's|MSTD|Frontotemporal Lobe Dementias (FLDEM)|Complex, Disinhibition-Dementia-Parkinsonism-Amytrophy|Frontotemporal dementia (disorder)|Disinhibition-Dementia-Parkinsonism-Amyotrophy Complex|Wilhelmsen-Lynch Disease|Complices, Disinhibition-Dementia-Parkinsonism-Amytrophy|frontotemporal dementia|Frontotemporal Lobe Dementias|Frontotemporal dementia|FRONTOTEMPORAL DEMENTIA|Dementia, Frontotemporal|DEMENTIA, FRONTOTEMPORAL|FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS|FTLD-TDP|Lobe Dementias, Frontotemporal|Dementias, Ubiquitin-Positive Frontotemporal|Ubiquitin-Positive Frontotemporal Dementia|Dementia, Frontotemporal Lobe|Hereditary Dysphasic Disinhibition Dementia|Frontotemporal Lobe Dementia|Dementia, Frontotemporal Lobe (FLDEM)|Disinhibition Dementia Parkinsonism Amyotrophy Complex|FTD-PGRN|Frontotemporal Dementias|Frontotemporal Dementias, Ubiquitin-Positive|Frontotemporal Dementias, GRN-Related|Dementias, Frontotemporal Lobe|HDDD2|DEMENTIA, FRONTOTEMPORAL, WITH PARKINSONISM|Pick's disease|Lobe Dementia, Frontotemporal|FRONTOTEMPORAL LOBAR DEGENERATION WITH TAU INCLUSIONS|Frontotemporal Dementia with Parkinsonism|Frontotemporal Lobar Degeneration With Ubiquitin-Positive Inclusions|FTD|Disinhibition Dementia Parkinsonism Amytrophy Complex|Disease, Wilhelmsen-Lynch|Wilhelmsen Lynch Disease|FTLD with TDP-43 Pathology|FTLD-17 GRN|Frontotemporal Dementia, Ubiquitin Positive|Complex, Disinhibition-Dementia-Parkinsonism-Amyotrophy|GRN-Related Frontotemporal Dementias|Frontotemporal Dementia, GRN-Related|FTLD with TDP 43 Pathology|FTLD WITH TAU INCLUSIONS|Picks disease|dementia frontotemporal|Familial Pick Disease|Dementia, GRN-Related Frontotemporal|Frontotemporal Dementia with Parkinsonism-17|GRN Related Frontotemporal Dementia|Frontotemporal Lobe Dementia (FLDEM)|Complices, Disinhibition-Dementia-Parkinsonism-Amyotrophy|Dementias, GRN-Related Frontotemporal|Disinhibition-Dementia-Parkinsonism-Amyotrophy Complices|WILHELMSEN-LYNCH DISEASE|Frontotemporal Lobar Degeneration With Ubiquitin Positive Inclusions|Wilhelmsen-Lynch Diseases|FTD-GRN|Disinhibition-Dementia-Parkinsonism-Amytrophy Complex|Frontotemporal Dementia|MULTIPLE SYSTEM TAUOPATHY WITH PRESENILE DEMENTIA|Diseases, Wilhelmsen-Lynch|Familial Pick's Diseases|FTDP-17|FRONTOTEMPORAL LOBE DEMENTIA|Familial Picks Disease|HDDD1|Dementia, Hereditary Dysphasic Disinhibition|Familial Pick's Disease|DDPAC|Multiple System Tauopathy with Presenile Dementia|GRN-Related Frontotemporal Dementia|DISINHIBITION-DEMENTIA-PARKINSONISM-AMYOTROPHY COMPLEX|Pick's Diseases, Familial|WLD|Diseases, Familial Pick's|Dementia, Ubiquitin-Positive Frontotemporal|FRONTOTEMPORAL DEMENTIA WITH PARKINSONISM | Frontotemporal dementia |
C0058698 | A subfamily of G-PROTEIN-COUPLED RECEPTORS that bind the neurotransmitter DOPAMINE and modulate its effects. D2-class receptor genes contain INTRONS, and the receptors inhibit ADENYLYL CYCLASES. | d2 dopamine receptors|D2 Receptors, Dopamine|Dopamine D2 Receptors|D2 receptor|d2 receptor|dopamine d2 receptor|Receptor, Dopamine-D2|Dopamine D2 Receptor|Dopamine-D2 Receptor|Receptors, Dopamine D2|d2 receptors | Dopamine D2 Receptor |
C0206128 | Transmitter receptors on or near presynaptic terminals (or varicosities) which are sensitive to the transmitter(s) released by the terminal itself. Receptors for the hormones released by hormone-releasing cells are also included. | Autoreceptor|Autoreceptors | Autoreceptors |
C0027754 | Factors which enhance the growth potentialities of sensory and sympathetic nerve cells. | Neurotrophic Factors|Factors, Neuronotrophic|NGF|nerve growth factors|Neurotrophins|Neurotrophic Proteins|Neurotrophic Protein|Neuronotrophic Factors|Nerve growth factor|neurotrophins|Nerve Growth Factors|Nerve growth factor (substance)|Factors, Nerve Growth|Factors, Neurotrophic|neurotrophic factors|ngf|factor growth nerve|nerve growth factor | Nerve Growth Factors |
C0376152 | The soft, fatty tissue that fills the cavities of bones | Marrow|marrow | Marrow |
C0232341 | null | Vascular flow, increased|Increased blood flow|Increased vascular flow (finding)|blood flow increased|Increased vascular flow|increased blood flow|blood flow increasing | Increased vascular flow |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.